Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction

Half of readers will recommend first licensed e-cigarette

Fifty-five per cent of 119 respondents to a C+D poll said the MHRA's decision to license a device gives them an "e-cigarette I feel comfortable recommending”

EXCLUSIVE

More than half of pharmacists will change the advice they give to patients once the first licensed e-cigarette hits the market, a C+D poll has suggested.

The Medicines and Healthcare products Regulatory Agency (MHRA) told C+D earlier this month that it had licensed the e-Voke device – produced by British American Tobacco – in November because it is a “product of acceptable quality and an effective aid to smoking cessation”.

Although the product is not yet available to patients, 55% of 119 respondents to a C+D poll said the licensing will affect the advice they give, because there will be an “e-cigarette on the market that I feel comfortable recommending”.

Twenty-five per cent of respondents to the poll – which ran from December 9-15 – said they will never recommend an e-cigarette, even if it is licensed. The remaining 20% said the MHRA’s decision would not affect them because they already recommend the devices.

 

Would you feel comfortable recommending a licensed e-cigarette?

We want to hear your views, but please express them in the spirit of a constructive, professional debate. For more information about what this means, please click here to see our community principles and information

Related Content

Topics

         
Pharmacy Manager
Guernsey
£70,000

Apply Now
Latest News & Analysis
See All
UsernamePublicRestriction

Register

CD007901

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel